Recombinant Human CFTR Protein，His

The cystic fibrosis transmembrane conductance regulator (CFTR) is a vital protein that functions as a chloride channel in epithelial cells, playing a crucial role in maintaining the balance of salt and water across cell membranes. Mutations in the CFTR gene lead to cystic fibrosis (CF), a genetic disorder characterized by thick mucus production, respiratory problems, and impaired pancreatic function. Research on CFTR recombinant proteins has gained significant attention due to their potential to elucidate the mechanisms underlying CFTR function and dysfunction. The study of CFTR's structure, dynamics, and interaction with various cellular components is essential for understanding the molecular basis of CF and developing targeted therapies. By employing techniques such as protein expression in heterologous systems, site-directed mutagenesis, and advanced imaging methods, scientists aim to dissect the channel's gating mechanisms and ion transport properties. Furthermore, the characterization of CFTR recombinant proteins offers insights into how specific mutations affect its function, paving the way for the design of novel pharmacological agents, such as small molecules and gene therapies, that could restore CFTR activity and improve outcomes for individuals with cystic fibrosis. As research progresses, the integration of structural biology, biophysics, and pharmacology continues to enhance our understanding of CFTR, highlighting its significance as a therapeutic target and a model for studying ion channel diseases.